Correlation of acid α-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease
- 1 July 2005
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 361 (1-2) , 191-198
- https://doi.org/10.1016/j.cccn.2005.05.025
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From MilkPediatrics, 2004
- Enzyme replacement therapy in late‐onset Pompe's disease: A three‐year follow‐upAnnals of Neurology, 2004
- Twenty-two novel mutations in the lysosomal ?-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type IIHuman Mutation, 2003
- Enzyme replacement therapy in the mouse model of Pompe diseaseMolecular Genetics and Metabolism, 2003
- Enzyme therapy for Pompe disease with recombinant human α‐glucosidase from rabbit milkJournal of Inherited Metabolic Disease, 2001
- Recombinant human acid ??-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trialGenetics in Medicine, 2001
- Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counsellingEuropean Journal of Human Genetics, 1999
- Prevalence of Lysosomal Storage DisordersJAMA, 1999
- Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the diseaseAmerican Journal of Medical Genetics, 1998
- Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail.Journal of Clinical Investigation, 1998